Summary
The restoration or de novo engineering of heart structures poses a challenge because of the unique structure and physical properties of the heart. The heart is a heterogeneous, complex helical structure with asymmetric and anisotropic features. Hence, it is variably built and consists of spiraling muscle bands (first described by Torrent-Guasp), valves, coronary vessels, and a conduction system. Therefore, successful construction of muscular or valvular grafts needs to meet specific prerequisites, such as mechanical stability, optimal porosity, and contractile function. A series of studies have reported on various mixtures of scaffolds and (stem) cells and subsequent production of spontaneously contractile cardiac grafts in vitro. In vivo studies have provided evidence of engraftment of such bioartificial myocardial grafts and of improved heart function of the host. Two fundamental types of bioartificial/engineered valves have been reported: decellularized xenogeneic valves and recellularized valves with the recipient’s own cells. Large-scale clinical results are awaited. Finally, bioartificial vessels are being produced, either through de novo construction from collagens and cells or from previously harvested recipient’s own fibroblasts and endothelial cells. The main goal envisioned here is long-term patency following implantation in vivo. This review surveys upon recent developments and indicates caveats in the field of tissue engineering of cardiac, valvular, and vascular structures.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Buckberg, G. D. (2002) Basic science review: the helix and the heart. J. Thorac. Cardiovasc. Surg. 124, 863–883.
Buckberg, G. D., Coghlan, H. C., and Torrent-Guasp. F. (2001) The structure and function of the helical heart and its buttress wrapping. V. Anatomic and physiologic considerations, in the healthy and failing heart. Semin. Thorac. Cardiovasc. Surg. 13, 358–385 (review).
Pasumarthi, K. B. and Field, L. J. (2002) Cardiomyocyte cell cycle regulation. Circ. Res. 90, 1044–1054.
Moscona, A. (1959) Tissues from dissociated cells. Sci. Am. 200, 132–134.
Moscona, A. and Moscona, H. (1952) The dissociation and aggregation of cells from organ rudiments of the early chick embryo. J. Anat. 86, 287–301.
Eschenhagen, T. and Zimmermann, W. H. (2005) Engineering myocardial tissue. Circ. Res. 97(12), 1220–1231.
Leor, J. and Cohen, S. (2004) Myocardial tissue engineering: creating a muscle patch for a wounded heart. Ann. N. Y. Acad. Sci. 1015, 312–319 (review).
Leor, J., Amsalem, Y., and Cohen, S. (2005) Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol. Ther. 105(2), 151–163 (review).
Barron, V., Lyons, E., Stenson-Cox, C., McHugh, P. E., and Pandit, A. (2003) Bioreactors for cardiovascular cell and tissue growth: a review. Ann. Biomed. Eng. 31(9), 1017–1030 (review).
Shachar, M. and Cohen, S. (2003) Cardiac tissue engineering, ex-vivo: design principles in biomaterials and bioreactors. Heart Fail. Rev. 8, 271–276 (review).
Sikavitsas, V. I., Bancroft, G. N., and Mikos, A. G. (2002) Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J. Biomed. Mater. Res. 62, 136–148.
Bursac, N., Papadaki, M., White, J. A., Eisenberg, S. R., Vunjak-Novakovic, G., and Freed, L. E. (2003) Cultivation in rotating bioreactors promotes maintenance of cardiac myocyte electrophysiology and molecular properties. Tissue Eng. 9, 1243–1253.
Kofidis, T., Lenz, A., Boublik, J., Akhyari. P., Wachsmann. B., Mueller-Stahl. K., Hofmann, M., and Haverich, A. (2003) Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. Biomaterials 24, 5009–5014.
Akhyari, P., Fedak, P. W., Weisel, R. D., Lee, T. Y., Verma, S., Mickle, D. A., and Li, R. K. (2002) Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation 106 (12 Suppl. 1), I137–I142.
Zimmermann, W. H., Schneiderbanger, K., Schubert, P., Didie, M., Munzel, F., Heubach, J. F., Kostin, S., Neuhuber, W. L., and Eschenhagen, T. (2002) Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 90, 223–230.
Kofidis, T., Akhyari, P., Boublik, J., Theodorou, P., Martin, U., Ruhparwar, A., Fischer, S., Eschenhagen, T., Kubis, H. P., Kraft, T., Leyh, R., and Haverich, A. (2002) In vitro engineering of heart muscle: artificial myocardial tissue. J. Thorac. Cardiovasc. Surg. 124, 63–69.
Kofidis, T., Lebl, D. R., Martinez, E. C., Hoyt, G., Tanaka, M., and Robbins R. C. (2005) Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 112(9 Suppl.), I173–I177.
Cannizzaro, S. M., Padera, R. F., Langer, R., Rogers, R. A., lack, F. E., Davies, M. C., Tendler, S. J., and Shakesheff, K. M. (1998) A novel biotinylated degradable polymer for cell interactive applications. Biotechnol. Bioeng. 58, 529–535.
Lee, C. R., Grad, S., Gorna, K., Gogolewski, S., Goessl, A., and Alini, M. (2005) Fibrin-polyurethane composites for articular cartilage tissue engineering: a preliminary analysis. Tissue Eng. 11, 1562–1573.
Jaquiery, C., Schaeren, S., Farhadi, J., Mainil-Varlet, P., Kunz, C., Zeilhofer, H. F., Heberer, M., and Martin, I. (2005) In vitro osteogenic differentiation and in vivo bone-forming capacity of human isogenic jaw periosteal cells and bone marrow stromal cells. Ann. Surg. 242, 859–867, discussion 867–868.
Lim, J. Y., Taylor, A. F., Li, Z., Vogler E. A., and Donahue H. J. (2005) Integrin expression and osteopontin regulation in human fetal osteoblastic cells mediated by substratum surface characteristics. Tissue Eng. 11, 19–29.
Mauney, J. R., Jaquiery, C., Volloch, V., Heberer, M., Martin, I., and Kaplan D. L. (2005) In vitro and in vivo evaluation of differentially demineralized cancellous bonescaffolds combined with human bone marrow stromal cells for tissue engineering. Biomaterials 26, 3173–3185.
Rosso, F., Giordano, A., Barbarisi, M., and Barbarisi, A. (2004) From cell-ECM interactions to tissue engineering. J. Cell Physiol. 199, 174–180 (review).
Eschenhagen, T. and Zimmermann, W. H. (2005) Engineering myocardial tissue. Circ. Res. 97, 1220–1231.
Rabkin, E. and Schoen, F. J. (2002) Cardiovascular tissue engineering. Cardiovasc. Pathol. 11, 305–317.
Bouhadir, K. H., Lee, K. Y., Alsberg, E., Damm, K. L., Anderson, K. W., and Mooney, D. J. (2001) Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol. Prog. 17, 945–950.
Khang, G., Lee, S. J., Lee, J. H., Kim, Y. S., and Lee, H. B. (1999) Interaction of fibroblast cells on poly(lactide-co-glycolide) surface with wettability chemogradient. Biomed. Mater. Eng. 9, 179–187.
Karageorgiou, V. and Kaplan, D. (2005) Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26, 5474–5491 (review).
Kelm, J. M., Diaz Sanchez-Bustamante, C., Ehler, E., Hoerstrup, S. P., Djonov, V., Ittner, L., and Fussenegger, M. (2005) VEGF profiling and angiogenesis in human microtissues. J. Biotechnol. 118, 213–229.
Yao, C., Prevel, P., Koch, S., Schenck, P., Noah, E. M., Pallua, N., and Steffens, G. (2004) Modification of collagen matrices for enhancing angiogenesis. Cells Tissues Organs 178, 189–196.
Narmoneva, D. A., Vukmirovic, R., Davis, M. E., Kamm, R. D., and Lee, R. T. (2004) Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation 110, 962–968.
Marui, A., Kanematsu, A., Yamahara, K., Doi, K., Kushibiki, T., Yamamoto, M., Itoh, H., Ikeda, T., Tabata, Y., and Komeda, M. (2005) Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation. J. Vasc. Surg. 41, 82–90.
Ito, A., Ino, K., Hayashida, M., Kobayashi, T., Matsunuma, H., Kagami, H., Ueda, M., and Honda, H. (2005) Novel methodology for fabrication of tissue-engineered tubular constructs using magnetite nanoparticles and magnetic force. Tissue Eng. 11, 1553–1561.
Shimizu, K., Ito, A., and Honda, H. (2005) Enhanced cell-seeding into 3D porous scaffolds by use of magnetite nanoparticles. J. Biomed. Mater. Res. B Appl. Biomater. October 21 (Epub ahead of print).
Papadaki, M., Bursac, N., Langer, R., Merok, J., Vunjak-Novakovic, G., and Freed, L. E. (2001) Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am. J. Physiol. Heart Circ. Physiol. 280, H168–H178.
Bursac, N., Papadaki, M., Cohen, R. J., Schoen, F. J., Eisenberg, S. R., Carrier, R., Vunjak-Novakovic, G., and Freed, L. E. (1999) Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am. J. Physiol. 277 (2 Pt. 2), 433–444.
Cohen, S. and Leor, J. (2004) Rebuilding broken hearts. Biologists and engineers working together in the fledgling field of tissue engineering are within reach of one of their greatest goals: constructing a living human heart patch. Sci. Am. 291, 44–51.
Zimmermann, W. H. and Eschenhagen, T. (2003) Cardiac tissue engineering for replacement therapy. Heart Fail. Rev. 8, 259–269 (review).
Zimmermann, W. H., Schneiderbanger, K., Schubert, P., Didie, M., Munzel, F., Heubach, J. F., Kostin, S., Neuhuber, W. L., and Eschenhagen T. (2002) Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 90, 223–230.
Ozawa, T., Mickle, D. A., Weisel, R. D., Matsubayashi, K., Fujii, T., Fedak, P. W., Koyama, N., Ikada, Y., and Li, R. K. (2004) Tissue-engineered grafts matured in the right ventricular outflow tract. Cell Transplant. 13, 169–177.
Ozawa, T., Mickle, D. A., Weisel, R. D., Koyama, N., Ozawa, S. and Li, R. K. (2002) Optimal biomaterial for creation of autologous cardiac grafts. Circulation 106(12 Suppl. 1), I176–I182.
Kofidis, T., Akhyari, P., Boublik, J., Theodorou, P., Martin, U., Ruhparwar, A., Fischer, S., Eschenhagen, T., Kubis, H. P., Kraft, T., Leyh, R., and Haverich, A. (2002) In vitro engineering of heart muscle: artificial myocardial tissue. J. Thorac. Cardiovasc. Surg. 124, 63–69.
Krupnick, A. S., Balsara, K. R., Kreisel, D., Riha, M., Gelman, A. E., Estives, M. S., Amin, K. M., Rosengard, B. R., and Flake A. W. (2004) Fetal liver as a source of autologous progenitor cells for perinatal tissue engineering. Tissue Eng. 10, 723–735.
Li, R. K., Jia, Z. Q., Weisel, R. D., Mickle, D. A., Choi, A., and Yau T. M. (1999) Survival and function of bioengineered cardiac grafts. Circulation 100(19 Suppl.), II63–II69.
Zimmermann, W. H., Melnychenko, I., and Eschenhagen T. (2004) Engineered heart tissue for regeneration of diseased hearts. Biomaterials 25, 1639–1647 (review).
Shimizu, T., Yamato, M., Isoi, Y., Akutsu, T., Setomaru, T., Abe, K., Kikuchi, A., Umezu, M., and Okano T. (2002) Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ. Res. 90, e40.
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W., and Prasher D. (1994) Green fluorescent protein as a marker for gene expression. Science 263, 802–805.
Orlic, D., Hill, J. M., and Arai A. E. (2002) Stem cells for myocardial regeneration. Circ. Res. 91, 1092–1102 (review).
Melton, L. (2005) Imaging: the big picture. Nature 437, 775–779.
Saeed, M., Saloner, D., Weber, O., Martin, A., Henk, C., and Higgins, C. (2005) MRI in guiding and assessing intramyocardial therapy. Eur. Radiol. 15, 851–863.
De, A. and Gambhir, S. S. (2005) Noninvasive imaging of protein-protein interactions from live cells and living subjects using bioluminescence resonance energy transfer. FASEB J. 19, 2017–2019.
Rodriguez-Porcel, M., Gheysens, O., Chen, I. Y., Wu, J. C., and Gambhir, S. S. (2005) Image-guided cardiac cell delivery using high-resolution small-animal ultrasound. Mol. Ther. 12, 1142–1147.
Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S., and Weiss, S. (2005) Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538–544 (review).
Wu, J. C., Chen, I. Y., Wang, Y., Tseng, J. R., Chhabra, A., Salek, M., Min, J. J., Fishbein, M. C., Crystal, R., and Gambhir, S. S. (2004) Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. Circulation 110, 685–691.
Su, H., Forbes, A., Gambhir, S. S., and Braun, J. (2004) Quantitation of cell number by a positron emission tomography reporter gene strategy. Mol. Imaging Biol. 6, 139–148.
Balsam, L. B., Wagers, A. J., Christensen, J. L., Kofidis, T., Weissman, I. L., and Robbins, R. C. (2004) Haematopoietic stem cells adopt mature hematopoietic fates in ischemic myocardium. Nature 428, 668–673.
Stein, P. D., Riddle, J. M., Kemp, S. R., Lee, M. W., Lewis, J. W., and Magilligan, D. J., Jr. (1985) Effect of warfarin on calcification of spontaneously degenerated porcine bioprosthetic valves. J. Thorac. Cardiovasc. Surg. 90, 119–125.
Staab, M. E., Nishimura, R. A., Dearani, J. A., and Orszulak T. A. (1998) Aortic valve homografts in adults: a clinical perspective. Mayo Clin. Proc. 73, 231–238 (review).
Neuenschwander, S. and Hoerstrup, S. P. (2004) Heart valve tissue engineering. Transpl. Immunol. 12, 359–365 (review).
Grimm, M., Grabenwoger, M., Eybl, E., Moritz, A., Bock, P., Muller, M. M., and Wolner, E. (1992) Improved biocompatibility of bioprosthetic heart valves by L-glutamic acid treatment. J. Card. Surg. 7, 58–64.
Leukauf, C., Szeles, C., Salaymeh, L., Grimm, M., Grabenwoger, M., Losert, U., Moritz, A., and Wolner, E. (1993) In vitro and in vivo endothelialization of glutaraldehyde treated bovine pericardium. J. Heart Valve Dis. 2, 230–235.
Steinhoff, G., Stock, U., Karim, N., Mertsching, H., Timke, A., Meliss, R. R., Pethig, K., Haverich, A., and Bader A. (2000) Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 102(19 Suppl. 3), III50–III55.
Stock, U. A., Nagashima, M., Khalil, P. N., Nollert, G. D., Herden, T., Sperling, J. S., Moran, A., Lien, J., Martin, D. P., Schoen, F. J., Vacanti, J. P., and Mayer, J. E., Jr. (2000) Tissue-engineered valved conduits in the pulmonary circulation. J. Thorac. Cardiovasc. Surg. 119 (4 Pt 1), 732–740.
Schenke-Layland, K., Vasilevski, O., Opitz, F., Konig, K., Riemann, I., Halbhuber, K. J., Wahlers, T., and Stock, U. A. (2003) Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J. Struct. Biol. 143, 201–208.
Schenke-Layland, K., Opitz, F., Gross, M., Doring, C., Halbhuber, K. J., Schirrmeister, F., Wahlers, T., and Stock, U. A. (2003) Complete dynamic repopulation of decellularized heart valves by application of defined physical signals – an in vitro study. Cardiovasc. Res. 60, 497–509.
Korossis, S. A., Booth, C., Wilcox, H. E., Watterson, K. G., Kearney, J. N., Fisher J., and Ingham, E. (2002) Tissue engineering of cardiac valve prostheses II: biomechanical characterization of decellularized porcine aortic heart valves. J. Heart Valve Dis. 11, 463–471.
Zhao, D. E., Li, R. B., Liu, W. Y., Wang, G., Yu, S. Q., Zhang, C. W., Chen, W. S., and Zhou, G. X. (2003) Tissue-engineered heart valve on acellular aortic valve scaffold: in-vivo study. Asian Cardiovasc. Thorac. Ann. 11, 53–56.
Konertz, W., Dohmen, P. M., Liu, J., Beholz, S., Dushe, S., Posner, S., Lembcke, A., and Erdbrugger, W. (2005) Hemodynamic characteristics of the matrix P decellularized xenograft for pulmonary valve replacement during the Ross operation. J. Heart Valve Dis. 14, 78–81.
Stock, U. A., Skamoto, T., Hatsuoka, S., Martin, D. P., Nagashima, M., Moran, A., Moses, M. A, Khalil, P. N., Schoen, F. J., Vacanti, J. P., and Mayer, J. E. (2000) Patch augmentation of the pulmonary artery using autologous cells and biodegradable polymers. J. Thorac. Cardiovasc. Surg. 120, 1158–1168.
Rieder, E., Seebacher, G., Kasimir, M. T., Eichmair, E., Winter, B., Dekan, B., Wolner, E., Simon, P., and Weigel, G. (2005) Tissue engineering of heart valves: decellularized porcine and human valvescaffolds differ importantly in residual potential to attract monocytic cells. Circulation 111, 2792–2797.
Sodian, R., Sperling, J. S., Martin, D. P., Egozy, A., Stock, U., Mayer, J. E., Jr., and Vacanti, J. P. (2000) Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering. Tissue Eng. 6, 183–188.
Masters, K. S., Shah, D. N., Walker, G., Leinwand, L. A., and Anseth K. S. (2004) Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials. J. Biomed. Mater. Res. A. 71, 172–180.
Sutherland, F. W., Perry, T. E., Yu, Y., Sherwood, M. C., Rabkin, E., Masuda, Y., Garcia, G. A., McLellan, D. L., Engelmayr, G. C., Jr., Sacks, M. S., Schoen, F. J., and Mayer, J. E., Jr. (2005) From stem cells to viable autologous semilunar heart valve. Circulation 111, 2783–2791.
Ramamurthi, A. and Vesely, I. (2005) Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves. Biomaterials 26, 999–1010.
Mol, A., Driessen, N. J., Rutten, M. C., Hoerstrup, S. P., Bouten, C. V., and Baaijens, F. P. (2005) Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach. Ann. Biomed. Eng. 33, 1778–1788.
L’Heureux, N., Dusserre, N., Konig, G., victor, B., Keire, P., Wight, T.N., Chronos, N.A., kyles, A.E., Gregory, C.R., Hoyt, G., Robbins, R.C., and McAllistu T.N. (2006) Human tissue-engineered blood vessels for adult arterial revascularization. Nat.Med. (12), 361–365.
Isenberg, B. C., Williams, C., and Tranquillo, R. T. (2006) Small-diameter artificial arteries engineered in vitro. Circ. Res. 98, 25–35.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this protocol
Cite this protocol
Kofidis, T., Müller-Stahl, K., Haverich, A. (2007). Myocardial Restoration and Tissue Engineering of Heart Structures. In: Hauser, H., Fussenegger, M. (eds) Tissue Engineering. Methods in Molecular Medicine™, vol 140. Humana Press. https://doi.org/10.1007/978-1-59745-443-8_15
Download citation
DOI: https://doi.org/10.1007/978-1-59745-443-8_15
Publisher Name: Humana Press
Print ISBN: 978-1-58829-756-3
Online ISBN: 978-1-59745-443-8
eBook Packages: Springer Protocols